Part Details | USP POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS
6505-01-266-8634
Alternate Parts: NDC62037072001, NDC62037-0720-01, NDC58177020211, NDC58177-0202-11, NDC58177020204, NDC58177-0202-04, NDC00093531101, NDC00093-5311-01, NDC00085078781, NDC00085-0787-81, NDC00085078701, NDC00085-0787-01, KDUR TABLETS, K-DUR TABLETS, KDUR, K-DUR, NDC00245005801, NDC00245-0058-01, NDC00245005811, NDC00245-0058-11, NDC59930171401, NDC59930-1714-01, 6505-01-266-8634, 01-266-8634, 6505012668634, 012668634
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | OCT 31, 1987 | 01-266-8634 | 37202 ( POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-266-8634
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC62037-0720-01 | 325V9 | ANDRX PHARMACEUTICALS INC |
| NDC58177-0202-11 | 0TEK5 | ETHEX CORPSUB OF K-V PHARMACEUTICAL CO |
| NDC58177-0202-04 | 0TEK5 | ETHEX CORPSUB OF K-V PHARMACEUTICAL CO |
| NDC00093-5311-01 | 80608 | LEMMON CO |
| NDC00085-0787-81 | 1F095 | SCHERING-PLOUGH CORPORATION |
| NDC00085-0787-01 | 1F095 | SCHERING-PLOUGH CORPORATION |
| K-DUR TABLETS | 1F095 | SCHERING-PLOUGH CORPORATION |
| K-DUR | 1F095 | SCHERING-PLOUGH CORPORATION |
| NDC00245-0058-01 | 51860 | UPSHER-SMITH LABORATORIES, INC. |
| NDC00245-0058-11 | 51860 | UPSHER-SMITH LABORATORIES, INC. |
| NDC59930-1714-01 | 07QS0 | WARRICK PHARMACEUTICALS INC |
Technical Data | NSN 6505-01-266-8634
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | STRIP |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB1500.000 MILLIGRAMS POTASSIUM CHLORIDE |
| FEATURES PROVIDED | UNIT DOSE |
| THERAPEUTIC EQUIVALENT | K-DUR BY KEY PHARMACEUTICALS |
| SPECIAL FEATURES | 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG |